The role of HIV-1 on genetic diversity, drug resistance, response to anti-retroviral, disease progression, and on In vivo HIV control as potential target for therapeutic vaccines Development (Part Seventeen)

Abstract

Current treatment of HIV/AIDS consists of a combination of three to five agents targeting different viral proteins, i.e. the reverse transcriptase, protease, integrase and envelope, and aims to suppress viral replication below detectable levels.